This essay analyzes the pharma industry by looking at the historical developments of the industry to the current situation in the Pharmaceutical industry which has become a multibillion dollar industr

************ *** ************** industry ** a crucial component of *** ****** ******* because ** is ********* **** *** discovery *** ********** ** medications and drugs that **** a crucial **** ** treatment ** ********** ** **** ** ******* illnesses The ************** ******** ** ******** ** **** ******* and ****** ********* *** ******* ******** ***** is ****** ********* **** isolation *********** and ******** ***** drug ******* ****** *** ***** ** *** **** century ***** to **** period ****** **** ***** work ** ***** *** error methods as **** ** ********* ** ***** **** plants animals *** minerals ********* medicinal properties ***** the pharmaceutical industry ** * multibillion-dollar ******** **** ******** and produces ********** **** ********* for *** ****** ***** ********* ***** *** ************ ** ******** **** ********** and ********* ***** *** 20th ******* *** been crucial *** *** ****** ** the ************** ******** **** paper ******* ** *** ******* of **** development *** ******* ********* ** *** pharmaceutical ******** including ******* *** ********** ** expansion ** *** ****** ************** ****************** ******* ************* Hindu and ******* ********* *** ******** as *** first human societies ** manipulate animal ******** *** plants for ***** medicinal ****** For ******** ** 2nd ******* ** ***** *** a blossoming alchemy school in ********** ***** where *** ******** **** ******** ********* ********* (Dailey ***** Similarly *** ******* **** **** ******** ****** to ***** ***** ** ***** ******* *** ********* **** ********** *********** to ****** *** *************** ******* **** ** *** ***** ******** used by ********* *** ***** ** *** today A good **** in point ** *** use ** castor oil *** Senna **** to ***** ************ ** **** ** *** use of ********** ****** ** *********** *** *** ** plants ********** ********* *** also ********* ** ***** ******* ***** In ****** *************** ephedrine *********** *** **** **** *** ********* ** ******* *** **** ***** * Greek ********* ** *** ******** **** ********** ** ******* * ******** ** which ** stocked ***** *** ****** ***** *************** *** ***** as * component ** *********** ** ***** ** **** **** ***** ** the father ****** day drug ********* ** ********* and **** *********** ******* ** instead ** using ******** ********** ** well as *********** *** need ** identify *** *********** *** *** ******* ** plant specimen ** ** **** *** **** making (Dailey 2016)The ********** of **** ****** or pharmacies ***** back to 16century *** **** Century London ***** ************ **** ****** * ***** **** ** *** ***** by **** James * ******* **** **** ******* of *** societies ** apothecaries ***** open apothecaries or ********** ** London ***** **** ** ** ******** **** ********* ******* ***** **** ****** ****** the foundation *** *** pharmaceutical ******* ** Great ******* ** **** which ********* *** ******** ** pharmacists **** *** ****** norm ***** ************ associations ** pharmacists are tasked **** ********* ** education *** **************** ** *** *********** US ** *** ******* market *** ************** ******** ********* *** ** also ***** *** ******* ******** in ************** ********** *** ******** *** US industry *********** ********* to *** global ******** because ** currently ** * * ******** of ********** **** *** ********* (PhaRMA *** *** ****** ****** ************** ******** ******* ************* 810000 ****** who work ** ********* ****** within *** ******** ************ *** pharmaceutical industry supports *** creates ****** ** million **** ****** *** ****** ****** economy ******* *** ***** **** ******* **** ******** and ********** ** ************** companies careers with ****** companies within *** ***** pharmaceutical supply chain ** well ** **** created *** ** the economic ********** ****** the ************** ******** and its workforce ******* *** ************** industry supports **** paying **** ** **** requires employees **** a **** ***** ** skills **** indicates that the workers ****** *** pharmaceutical ******** **** ** highly ******* starting with **** administrative ****** ** *** ** * ********** who work in **** *********** and ****** ******* *** *** ************** ******** ******** for *** ******* ***** in ******** ********** **** it ***** to R&DThe ************** industry ** **** ******* **** ********** **** ********* ***** ***** generics *** *********** **** Additionally ** *** also ****** highly *********** Biologics *** * crucial ******* ****** *** ************** ******** because ** ** *********** *** * quarter ** *** *** *********** and ***** ********** ******** ****** ** ******** ** ** ******** ** *** **** *** Drug ************** ***** ******** *** ***** ******** ** be **** *** ***** ********* ** ** be **** in drug ****** *** ***** ********** ** *** ** is ******* for the ****** ** *** ********* ** **** *** Counter ***** as ailments requiring **** of ***** ***** ******** with *** ****** ************** ****** ** *** ** as one ** *** World’s ******* pharmaceutical ****** ** ********** because ** its pricing ****** ************ *** industry ** ****** ** * ********* patent ***** environment ** **** ** ********** ******* **** ** efficacy ***** ******* *** ****** of *** ******* are ******* *** *** ******* of ******** ****** *** US ****** *** government has also **** ******* ** *** growth ** the ************** ****** especially ******* *** ** ********** ******** pharmaceutical and ********** research ***** is crucial for *** *********** ** ***** **** ******* with *** fact *** US ****** has * ******* ********** research base *** * ******* biotechnology ****** are ******* **** contribute the *********** *** ****** ** *** ******** ************** industrySubsectors ** *** ************** *********** ********** ************** ************ section ** the ******** ** concerned **** the ********** ** ***** derived **** chemical ********* The industry ******** ********* ******** and *********** ** **** ** ************ ******** ****** ** drugs ** **** animals *** humans Creative **** of drug ********* *** creation ** ********* ***** *** ************ property rights **** any ***** ******** **** **** *** US ****** **** of ** years ******** ** ******** **** ** *** industry *** industry *********** expiring ******* ** ********** *** ********* **** revitalize dying ******* ******* Innovation within pharmaceutical industry ** carried out by ***** ************** ******* partnerships with ******* *** ********** producers ********** ************** ******** are priced ** **** a way **** they reflect *** R&D ********** **** on *** production ** **** innovationBiopharmaceutical IndustryThis ****** of *** industry ** concerned **** ********** of drugs **** **** ***** The ***** ********* **** include ******** ********** ********** *** ******* materials used *** **** *********** ** *********** ******** *** drugs ******* ** **** ****** *** other ***** instead ** deriving ******** **** the ********** ****** **** ** ************** ********** ** ***** **** transgenic ********* ********** ******* *** ****** that **** ********* ******* ************ *** *** purposes of **** ********** *** been ************* ** **** ****** *** ******** ****** on ******** by ******** ************ *** ***** ********* *** ******** ** **** ********* ** ***** ************ **** are ******* of commercialization *** **** ********* these ***** ************ **** fund ***** ******** worksBiologics Biologics is a ******* of *** ************** ******** that ***** **** ********** of ******** ***** ********** ******* *** *********** ******** ******** ******** ** this ****** ** *** industry **** **** ******* ** eradication ** disease **** as ****** ***** and polio ******** **** **** * vital **** ** ******* ** infectious ******** Although ************** ********* ******* **** with ********** ** ********* and ***** **** *** ************ by acquiring ************* ********* **** **** **** production ** ********* Alliances and ***** ******** ** R&D *** ********** ** ********* are common ****** this ****** ** *** ******** *** alliances *** ******* on *** ****** **** ***** *** ****** ** good at ********** *** ***** ** ******* that *** the ******** ** ************* *** ********** ******* ** create valueGeneric ************** IndustryThis sector ******** ******* ******** of ********** ***** *** ******* ******** have *** **** ******** ****** *** even *** ****** ** administration ******* ***** and ********** ** *** ** *** only ******** **** the patent *** ******* ** * ************ has ************ ********** * ****** ********** Nevertheless *** *** drug **** meet *** *********** required by *** **** *** **** ************** in the ** ************ the manufacturer **** ****** ********* from *** Food and Drug Administration ****** commencing *** ********** of generic medications *** ***** ** *** ***** ********** pharmaceutical product ******* One ** *** leading characteristics ** ******* ************** ******** ** **** **** *** ******* ****** ** compete **** *** original ******** ******* ******* ** **** ****** ***** **** play ** *** ********* sector ** *** ************** ******** which ******* ***** with *** production ** *********** Factors such ** ********** ** ********** ************ chains and volume ** ***** *** some ** *** ******* that affect ****** ****** ** generic pharmaceutical products However *** ********* is ** ****** *** volume ** sales rather **** ****** to **** ******* this ******** *** **** ******** are fairly ****** *** ********** takeaway *** ********* ** **** ****** ** **** ****** ****** *** government regulation ** **** ** ******** ** ** critical importance to producers ** *** ******* ****** ** the industry Usually *********** allow generics ** ***** ** combat ************ **** are a threat ** *** *********** ** the ************** industry ****** ******* ************* ***** ** ************** ********* ** *** ****** IndustryCompanies operating ** *** ****** ****** *** ***** **** unending ********** **** affect *** these companies ******* *** ******* **** *** likely ** affect a ****** ** *** ************** industry ********* ******* ********** *********** ******** ******** ************* *** ********* *********** ***** ******* *** ****** to affect *** expansionary ****** ** * ******* *** **** **** ***** ** **** ** *** factors that may ****** *** ********* ** pharmaceutical companies in *** ** pharmaceutical ****************** ************* are different ********** ************ ** ***** ****** **** ******* different ************ *** *** organizations ********* ** ********* *** drugs ** * given market *** ******** ** *** ** ************** ********* **** **** ** ******** ***** by *** *** ********* ********** ************* must be ********* before ******** trials are ********* ** ****** In many ***** ********* ***** ** **** ** ******** ****** *** resources to ****** *** the submissions sent ** *** ********* for approval (World Finance *** ************ ***** *** also challenges **** ************ ******** *********** that **** ** **** *** ******** **** ********* the competitiveness ** a ************** ******************* ******** regulationIn **** ********* there ** * *********** on ******* ** innovative pharmaceutical ************* ******* **** ******* ***** monopolize health ********* making **** ************ ** the **** ****** *********** ** ******* ** **** *********** affects *** ******* ** the ******* ** ****** ******* ***** from their *********** because ******* ******** **** ****** ** **** as *** ********** ** **** public *** ***** ***** ITIF 2016) **** *** ****** *** ******* ** *** ******* ** ****** ** unprotected ******* ******* *** ********** may *** up ***** ************ ************ ********* such ** ***** **** ****** innovationSupplementation ** data in patent ************** **** ********* data ********** **** an ********* is can ** high ** is **** ******* ** gather **** information ** ** common ********* *** organizations ** ***** *** ******* *** ****** the *********** ********** ********* ***** ******* ***** *** been restrictions ** this practice requiring the organizations ** ****** *** ****** applications **** **** *********** This ******* ******** because ** ** **** consuming ***** *** ****** *** ability ** *** company to ******* ************** ******** ** **** ** *** ************* ** **** productsPatent **** A **** intellectual property ********** ****** ** *** *** that ******** *** patent ****** **** *** appropriate ********** ** ******* ***** ******* (Wu ***** ***** **** ***** **** ***** ******* provisions *** patent ******* ***** allows ************** ********* ** ******* ****** ************ ****** ******* ***** ***** *** ****** *** affect *** ******** ** *** ***************** licensing **** ** *** case **** the ******* ****** of *** ************** industry ***** ********* *** allowed ** produce ******** ** patented ****** ** to patent already patented *********** **** flexibility is ********* ** the ***** agreement ***** requires **** Compulsory ******** will ** issued ** **** **** ****** such ** ******** *** limited ***** ***** ** ******** ************ *** non-exclusivity ***** ****** (World ***** Organization nd) *** ******* with **** ********* is **** offer *** compulsory ******** ******* ******** ****** ****** justification In **** instances *** are used to ******** ******* ** ************** ******** or ** ***** ***** ************* ** *** ******* of ******* companiesPricing ******* ** * ******* ****** ** ***** market ****** **** ******* When ***** controls *** put ** ***** it ******* ********* *** ************* ** ******* ***** ********** ** ************** research and **** development ** **** affects the ******* ** companies ** ****** their *********** innovative medicines ****** practices ** price ******** ******* ************* ********* ******* ***** prices *** *** ** ********** ** * ********** *** drug ****** ** a ****** ** ****** ********* ************ *********** ********* ******* *** in which the government groups ********* according ** *** conditions they that *** ****** a ********** ***** despite *** ***** ******** in ********** ** ********** of *** medicinesTariffs ***** foreign tariffs *** license **** ****** the ******* ** an ************ ** access ****** in * ***** country ***** factors ******* *** **** ** ***** to *** ****************** Using ****** ******** ******* *** ********** ** *** become possible *** easier to ********** ********* ** **** ********* ************ *** ************** industry ** ****** by challenges **** **** *** ********** *********** **** of *** challenges ******* ********** ** ********* ** ******** ** conduct research **** ********* ** **** ** ********** involving **** *********** *********** *** constant challenges are ********** ******* **** help the ************** ******** ** ****** ***** ** ***** *** *** *********** ** ****** diseases ** *** world ** **** ***** *** pharmaceutical ******** ********* ** ** * crucial part ** *** ******* as **** ** *** social ****** ** ******* *** ********** live ******* *************************** W J ****** Pharmaceutical ******** ********* **** ************************************************************* D Dalzell (2013) ** * ***** ******* ** top-selling drugs **** be ********* ********* ************************************************************************************************* **** Economic ******* *** ***************** Industry Helps Strengthen *** US ******* Retrieved **** ************************************************ (2015) ********** *** ***** ***** *** ************** ******** ** *** ** ********* **************************************************************** ******* **** ***** ** ******* ******** hits ************** ****** ************************************************************************************************************ Trade ************ **** Compulsory ********* ** *************** and ***** https://wwwwtoorg/english/tratop_e/trips_e/public_health_faq_ehtmWu * * ***** J S ***** The *********** ********** *** ********** Foundation ****** (2016) *** ******** ******** ****** Global Biopharma *********** * Worldwide ******* ********* *******************************************************************************************

Click here to download attached files: PhaRMA LASA.docx